These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 20041274

  • 21. Malignancy in systemic lupus erythematosus: relation to disease characteristics in 92 patients - a single center retrospective study.
    Kosałka-Węgiel J, Pacholczak-Madej R, Dziedzic R, Siwiec-Koźlik A, Spałkowska M, Milewski M, Zaręba L, Bazan-Socha S, Korkosz M.
    Rheumatol Int; 2024 Sep; 44(9):1701-1713. PubMed ID: 38850326
    [Abstract] [Full Text] [Related]

  • 22. Hodgkin's lymphoma in systemic lupus erythematosus.
    Bernatsky S, Ramsey-Goldman R, Isenberg D, Rahman A, Dooley MA, Sibley J, Boivin JF, Joseph L, Armitage J, Zoma A, Clarke A.
    Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
    Akawatcharangura P, Taechakraichana N, Osiri M.
    Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
    [Abstract] [Full Text] [Related]

  • 24. Risk of malignancy in women with systemic lupus erythematosus.
    Sweeney DM, Manzi S, Janosky J, Selvaggi KJ, Ferri W, Medsger TA, Ramsey-Goldman R.
    J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
    [Abstract] [Full Text] [Related]

  • 25. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
    Tallbacka KR, Pettersson T, Pukkala E.
    Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
    [Abstract] [Full Text] [Related]

  • 26. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus.
    Cobo-Ibáñez T, Urruticoechea-Arana A, Rúa-Figueroa I, Martín-Martínez MA, Ovalles-Bonilla JG, Galindo M, Calvo-Alén J, Olivé A, Fernández-Nebro A, Menor-Almagro R, Tomero E, Horcada L, Uriarte-Itzazelaia E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Bohorquez C, Montilla C, Santos G, Hernández-Cruz B, Vela P, Salgado E, Freire M, Hernández-Beriain JÁ, Díez-Álvarez E, Expósito L, Fernández-Berrizbeitia O, Velloso-Feijoo ML, Ibáñez-Barceló M, Lozano-Rivas N, Bonilla G, Moreno M, Raya E, Quevedo-Vila VE, Vázquez-Rodríguez TR, Ibáñez-Ruan J, Muñoz-Fernández S, Sánchez-Alonso F, Pego-Reigosa JM.
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):216-224. PubMed ID: 31529686
    [Abstract] [Full Text] [Related]

  • 27. Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    Bernatsky S, Clarke AE, Zahedi Niaki O, Labrecque J, Schanberg LE, Silverman ED, Hayward K, Imundo L, Brunner HI, Haines KA, Cron RQ, Oen K, Wagner-Weiner L, Rosenberg AM, O'Neil KM, Duffy CM, von Scheven E, Joseph L, Lee JL, Ramsey-Goldman R.
    J Rheumatol; 2017 Oct; 44(10):1484-1486. PubMed ID: 28765255
    [Abstract] [Full Text] [Related]

  • 28. Cancer risk in childhood-onset systemic lupus.
    Bernatsky S, Clarke AE, Labrecque J, von Scheven E, Schanberg LE, Silverman ED, Brunner HI, Haines KA, Cron RQ, O'Neil KM, Oen K, Rosenberg AM, Duffy CM, Joseph L, Lee JL, Kale M, Turnbull EM, Ramsey-Goldman R.
    Arthritis Res Ther; 2013 Oct; 15(6):R198. PubMed ID: 24267155
    [Abstract] [Full Text] [Related]

  • 29. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    Garnier C, Ribes D, Chauveau D, Huart A, Pugnet G, Adoue D, Prevot G, Alric L, Delobel P, Derumeaux H, Mengelle C, Sailler L, Moulis G.
    J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
    [Abstract] [Full Text] [Related]

  • 30. Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.
    Dey D, Kenu E, Isenberg DA.
    Lupus; 2013 Aug; 22(9):919-27. PubMed ID: 23857987
    [Abstract] [Full Text] [Related]

  • 31. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.
    Bae EH, Lim SY, Han KD, Jung JH, Choi HS, Kim CS, Ma SK, Kim SW.
    Lupus; 2019 Mar; 28(3):317-323. PubMed ID: 30712493
    [Abstract] [Full Text] [Related]

  • 32. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.
    Jung SM, Moon SJ, Kwok SK, Ju JH, Park KS, Park SH, Kim HY.
    Lupus; 2013 Aug; 22(9):885-91. PubMed ID: 23846231
    [Abstract] [Full Text] [Related]

  • 33. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
    Pastore DEA, Costa ML, Surita FG.
    Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
    [Abstract] [Full Text] [Related]

  • 34. Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
    Sousa S, Gonçalves MJ, Inês LS, Eugénio G, Jesus D, Fernandes S, Terroso G, Romão VC, Cerqueira M, Raposo A, Couto M, Nero P, Sequeira G, Nóvoa T, Melo Gomes JA, da Silva JC, Costa L, Macieira C, Silva C, Silva JA, Canhão H, Santos MJ.
    Rheumatol Int; 2016 Jul; 36(7):955-60. PubMed ID: 26979603
    [Abstract] [Full Text] [Related]

  • 35. Systemic lupus erythematosus and the risk of malignancy.
    Cibere J, Sibley J, Haga M.
    Lupus; 2001 Jul; 10(6):394-400. PubMed ID: 11434573
    [Abstract] [Full Text] [Related]

  • 36. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
    Björnådal L, Löfström B, Yin L, Lundberg IE, Ekbom A.
    Scand J Rheumatol; 2002 Jul; 31(2):66-71. PubMed ID: 12109649
    [Abstract] [Full Text] [Related]

  • 37. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
    Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, Aranow C, Dooley MA, Rajan R, Sénécal JL, Zummer M, Manzi S, Ramsey-Goldman R, Clarke AE.
    Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
    [Abstract] [Full Text] [Related]

  • 38. Increased congenital heart defects in children born to women with systemic lupus erythematosus: results from the offspring of Systemic Lupus Erythematosus Mothers Registry Study.
    Vinet É, Pineau CA, Scott S, Clarke AE, Platt RW, Bernatsky S.
    Circulation; 2015 Jan 13; 131(2):149-56. PubMed ID: 25355915
    [Abstract] [Full Text] [Related]

  • 39. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
    Chen YJ, Chang YT, Wang CB, Wu CY.
    Am J Med; 2010 Dec 13; 123(12):1150.e1-6. PubMed ID: 21183006
    [Abstract] [Full Text] [Related]

  • 40. Lupus cystitis in Korean patients with systemic lupus erythematosus: risk factors and clinical outcomes.
    Koh JH, Lee J, Jung SM, Ju JH, Park SH, Kim HY, Kwok SK.
    Lupus; 2015 Oct 13; 24(12):1300-7. PubMed ID: 26038343
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.